At present she shows impassive facies, dysarthric speech, marked telangiectasia of the bulbar conjunctiva, slight to moderate limb and truncal ataxia, hyporeflexia and flexor plantar response. Case 2.

NIDO-361, our clinical-stage candidate, is a treatment for Spinal and Bulbar Muscular Atrophy which is a rare and debilitating neuromuscular disease. Additional pipeline programs center around a novel ...

Signs of blepharospasm were never seen again, and there was no evidence of lesion recurrence 12 months after surgery. Figure 1 Conjunctival dermoid at the temporal bulbar conjunctiva in a mixed-breed, ...

A preferred method of using lissamine green for bulbar conjunctival staining includes using a total of 2 applications of the dye on the same strip, according to a study published in Optometry and ...

II. Degenerative and hemodynamic changes in bulbar conjunctiva of normotensive diabetic patients. New Eng. J. Med. 250:587–594, 1954.

Moreover, a unilateral, heterogenous, patchy, golden yellow to brown mottled or dusted pigment can be seen. Its appearance regarding size and degree of pigmentation can change over time. It is ...

Prednisolone Acetate Ophthalmic Suspension, 1% is indicated for the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.

The bulbar conjunctiva is a thin, vascularized membrane covering the sclera of the eye. Non-invasive imaging techniques have been utilized to assess the conjunctival vasculature as a means of studying ...

The treatment is administered as 1 drop into the conjunctival sac 2 to 4 times daily. During the first 24 to 48 hours, the dosing frequency may be increased to 1 application every 4 hours.

FLAREX® (fluorometholone acetate ophthalmic suspension) 0.1% is indicated for use in the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea ...

FLAREX® (fluorometholone acetate ophthalmic suspension) 0.1% is indicated for use in the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea ...